Researchers at the University of British Columbia reported the first human transplant of an ABO-incompatible kidney converted from blood type A to universal type O using engineered enzymes. Functioning without hyperacute rejection for two days post-transplant marks a significant step toward increasing organ availability and reducing transplantation wait times by overcoming donor-recipient blood-type incompatibility without aggressive immunosuppression.